Le Lézard
Classified in: Health, Business
Subject: TNM

Sharp Fluidics® acquires neoClose® Laparoscopic and Robotic Port Closure Technology


SAN FRANCISCO, April 7, 2020 /PRNewswire/ -- Sharp Fluidics®, LLC, a private medical device company whose innovative Operative Armour® System leads the way in open surgery closure efficiency and safety, announced the acquisition of neoClose®, a laparoscopic and robotic port site closure technology from neoSurgical, LTD. 

"This is a significant step to enhance Sharp Fluidics' product portfolio," said Doug Rimer, President, Sharp Fluidics, LLC. "We strive to introduce innovative thinking to surgical closure, and neoClose is highly complementary to our Operative Armour System. With Operative Armour, clinicians can self-dispense and self-secure their own suture needles in open surgery closures without scrub tech assistance, dramatically improving workflow efficiency while minimizing exposure to contaminated suture needles. neoClose enables us to now offer an extremely elegant and user-friendly, needle-less approach to perform safer, more efficient closure of minimally invasive surgeries."

neoClose® brings a simple, intuitive and reliable solution to assist the surgeon in closing port site defects, up to 3cm, following laparoscopic and robotic abdominal surgery. By utilizing bio-absorbable anchors with a pre-attached suture, neoClose® is changing the standard of care in port site closure.  neoClose® is faster, safer, and provides less port site pain than the standard practice of closing port sites.

"With the acquisition of neoClose, Sharp Fluidics has expanded its product offerings beyond traditional open surgery, now providing a faster and safer surgical closure option for clinicians performing minimally invasive and robotic surgery," said Mark Froimson, MD, MBA, Orthopedic Surgeon and Past President of the American Association of Hip and Knee Surgeons. "neoClose and Operative Armour reduce OR surgical times and improve OR staff safety, two of the most important initiatives that many leading hospitals have prioritized." 

About Sharp Fluidics®, LLC

Sharp Fluidics®, LLC a San Francisco Bay Area based surgical device company is a leader in development and marketing of innovative medical technologies and devices to improve surgical closure efficiency and safety. For more information on Sharp Fluidics, visit the Company's Web site at www.sharpfluidics.com.

Contacts.
Sharp Fluidics, LLC
Tom Keegan
[email protected]

SOURCE Sharp Fluidics, LLC


These press releases may also interest you

at 22:10
Getech, a world-leading locator of subsurface resources, is pleased to announce it has won a new contract with East Star Resources, a London-listed company focused on copper exploration, to locate porphyry copper...

at 22:00
BlackRock Asset Management Canada Limited ("BlackRock Canada"), an indirect, wholly-owned subsidiary of BlackRock, Inc. , today announced the final April 2024 cash distributions for the iShares Premium Money Market ETF. Unitholders of record on April...

at 21:40
TSX VENTURE COMPANIES None today. 24/04/24 - TSX Venture Exchange Bulletins TSX VENTURE COMPANIES BULLETIN V2024-1192 AUKA CAPITAL CORP. ("AUK.P") BULLETIN TYPE:  HaltBULLETIN DATE:  April 24, 2024TSX Venture Tier 2 Company  Effective at 5:10 a.m....

at 21:37
Ademi LLP is investigating HashiCorp for possible breaches of fiduciary duty and other violations of law in its transaction with IBM....

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:26
OKX, a leading Web3 technology company, has issued updates for April 24, 2024. OKX DeFi Launches 'zkSwap Bonus Event' Offering Users...



News published on and distributed by: